<SEC-DOCUMENT>0001209191-23-037192-index.html : 20230614
<SEC-HEADER>0001209191-23-037192.hdr.sgml : 20230614
<ACCEPTANCE-DATETIME>20230614190237
ACCESSION NUMBER:		0001209191-23-037192
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230613
FILED AS OF DATE:		20230614
DATE AS OF CHANGE:		20230614

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Smith Karen L.
		CENTRAL INDEX KEY:			0001639637

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40384
		FILM NUMBER:		231015604

	MAIL ADDRESS:	
		STREET 1:		C/O JAZZ PHARMACEUTICALS PLC
		STREET 2:		5TH FL, WATERLOO EXCHANGE, WATERLOO RD
		CITY:			DUBLIN L2 4
		STATE:			L2
		ZIP:			0

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Talaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001827506
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		570 PRESTON ST.
		STREET 2:		SUITE 400
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		502-398-9250

	MAIL ADDRESS:	
		STREET 1:		93 WORCESTER STREET
		CITY:			WELLESLEY
		STATE:			MA
		ZIP:			02481
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>